Scholarlink

<p><i>Staphylococcus aureus</i> (<i>S. aureus</i>) is an opportunistic, Gram-positive pathogen that forms significant clinical challenges due to its multidrug-resistant mechanisms, diverse virulence factors, and robust biofilm-forming capacity. One of the main drivers of antimicrobial resistance (AMR) is the selective pressure exerted by antibiotic use, necessitating alternative therapeutic strategies. Among these, quorum-sensing inhibitors (QSIs) have emerged as promising candidates for disrupting bacterial communication and reducing virulence without compromising bacterial viability. This review focuses on targeting <i>S. aureus</i> communication systems, particularly the accessory gene regulator (<i>agr</i>) quorum-sensing system. We first provide an overview of biofilm development strategies in <i>S. aureus</i>, define bacterial communication networks, and discuss the advantages and limitations of targeting these systems as a strategy for virulence attenuation. We also explore the interplay between regulatory systems within biofilms and how they influence each stage of biofilm maturation. The agr system comprises a network of proteins that can be selectively targeted to disrupt its signaling cascade. Potential intervention points include (1) obstruction of autoinducing peptide (AIP) synthesis, (2) degradation of preformed AIPs, (3) competitive inhibition or modification of the histidine kinase receptor AgrC, and (4) interference with downstream effectors such as AgrA and RNAIII. Given that the agr system primarily operates in the later stages of biofilm development, facilitating biofilm dispersal and upregulating virulence genes, QSIs alone may attenuate virulence yet risk persistent biofilm-associated infections. Accordingly, we emphasize the importance of combining QSIs with biofilm-disrupting or eradicating agents to reduce both biofilm formation and virulence, while minimizing the risk of resistance emergence. Future research should focus on optimizing such combinatorial strategies, evaluating in vivo efficacy, and ensuring safety and minimal off-target effects to facilitate clinical translation of QSIs as viable anti-virulence therapeutics against <i>S. aureus</i> infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hijacking the signal: a critical evaluation of quorum sensing inhibitors as a next-generation approach against Staphylococcus aureus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月2日

查看全文
  • Sama S. Eltaher,
  • Zeina Khattab,
  • Gina Walid,
  • Omar Loay,
  • Rana Emad,
  • Clara Hakim,
  • Mohamed Elhadidy

摘要

Staphylococcus aureus (S. aureus) is an opportunistic, Gram-positive pathogen that forms significant clinical challenges due to its multidrug-resistant mechanisms, diverse virulence factors, and robust biofilm-forming capacity. One of the main drivers of antimicrobial resistance (AMR) is the selective pressure exerted by antibiotic use, necessitating alternative therapeutic strategies. Among these, quorum-sensing inhibitors (QSIs) have emerged as promising candidates for disrupting bacterial communication and reducing virulence without compromising bacterial viability. This review focuses on targeting S. aureus communication systems, particularly the accessory gene regulator (agr) quorum-sensing system. We first provide an overview of biofilm development strategies in S. aureus, define bacterial communication networks, and discuss the advantages and limitations of targeting these systems as a strategy for virulence attenuation. We also explore the interplay between regulatory systems within biofilms and how they influence each stage of biofilm maturation. The agr system comprises a network of proteins that can be selectively targeted to disrupt its signaling cascade. Potential intervention points include (1) obstruction of autoinducing peptide (AIP) synthesis, (2) degradation of preformed AIPs, (3) competitive inhibition or modification of the histidine kinase receptor AgrC, and (4) interference with downstream effectors such as AgrA and RNAIII. Given that the agr system primarily operates in the later stages of biofilm development, facilitating biofilm dispersal and upregulating virulence genes, QSIs alone may attenuate virulence yet risk persistent biofilm-associated infections. Accordingly, we emphasize the importance of combining QSIs with biofilm-disrupting or eradicating agents to reduce both biofilm formation and virulence, while minimizing the risk of resistance emergence. Future research should focus on optimizing such combinatorial strategies, evaluating in vivo efficacy, and ensuring safety and minimal off-target effects to facilitate clinical translation of QSIs as viable anti-virulence therapeutics against S. aureus infections.